Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maximizing sinusoidal channels of HZSM-5 for high shape-selectivity to p-xylene.

Nature communications·2019
Same author

Correction: Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent metabolic reprogramming.

Cell death & disease·2019
Same author

RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2019
Same author

Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.

Surgical oncology·2019
Same author

Construction of a sp<sup>3</sup> /sp<sup>2</sup> Carbon Interface in 3D N-Doped Nanocarbons for the Oxygen Reduction Reaction.

Angewandte Chemie (International ed. in English)·2019
Same author

A versatile route to fabricate single atom catalysts with high chemoselectivity and regioselectivity in hydrogenation.

Nature communications·2019
Same journal

Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.

Cancer cell·2026
Same journal

Intratumoral B cells under stress.

Cancer cell·2026
Same journal

Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth.

Cancer cell·2026
Same journal

Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts.

Cancer cell·2026
Same journal

OpenIO: An open framework for AI-native immunotherapy.

Cancer cell·2026
Same journal

From prediction to interpretation in computational pathology.

Cancer cell·2026
See all related articles

Related Experiment Video

Updated: Sep 14, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.1K

TNBC's compass: Navigating prognosis with a cellular map.

Yi-Fan Zhou1, Ding Ma1, Zhi-Ming Shao1

  • 1Key Laboratory of Breast Cancer, Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

Cancer Cell
|July 18, 2025
PubMed
Summary
This summary is machine-generated.

Researchers discovered a stem-like tumor cell associated with poor outcomes in triple-negative breast cancer (TNBC). This finding, combined with T cell data, creates a new classification system for predicting prognosis and guiding treatment.

More Related Videos

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Related Experiment Videos

Last Updated: Sep 14, 2025

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.1K
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.1K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.4K

Area of Science:

  • Oncology
  • Immunology
  • Biomedical Imaging

Background:

  • Triple-negative breast cancer (TNBC) presents significant therapeutic challenges.
  • Identifying novel biomarkers for TNBC prognosis is crucial for effective treatment strategies.

Purpose of the Study:

  • To identify novel tumor cell subtypes in TNBC.
  • To correlate tumor cell characteristics and T cell spatial architecture with patient prognosis.
  • To develop a new classification system for TNBC.

Main Methods:

  • Utilized imaging mass cytometry to analyze tumor tissue.
  • Integrated spatial analysis of T cells within the tumor microenvironment.
  • Correlated identified cell types and spatial patterns with clinical outcome data.

Main Results:

  • Identified a distinct stem-like basoluminal tumor cell population.
  • This cell type is significantly associated with poor prognosis in TNBC patients.
  • Established a five-subtype classification integrating tumor cell phenotype and T cell spatial organization.

Conclusions:

  • The stem-like basoluminal tumor cell is a potential prognostic biomarker for TNBC.
  • The developed five-subtype classification system can predict prognosis and inform therapeutic decisions in TNBC.